Literature DB >> 12070022

Paraneoplastic myasthenia gravis correlates with generation of mature naive CD4(+) T cells in thymomas.

Philipp Ströbel1, Markus Helmreich, Georgios Menioudakis, Sharon R Lewin, Thomas Rüdiger, Andrea Bauer, Viola Hoffacker, Ralf Gold, Wilfred Nix, Berthold Schalke, Olaf Elert, Michael Semik, Hans Konrad Müller-Hermelink, Alexander Marx.   

Abstract

Myasthenia gravis (MG) is the leading paraneoplastic manifestation of thymomas and is probably related to the capacity of thymomas to mature and export potentially autoreactive T cells. Why some thymomas are MG associated (MG+) and others are not (MG-) has been unclear. We addressed this question by comparing the percentages of intratumorous naive mature CD45RA+ thymocytes in 9 MG(+) and in 13 MG(-) thymomas by fluorescence-activated cell sorting analysis. Our results show that intratumorous naive CD4 T cells were present in all MG(+) thymomas and in one MG(-) thymoma with the development of MG only 2 months after surgery. By contrast, the percentage of naive CD4(+) T cells was significantly reduced in all 13 MG(-) thymomas (P <.0001). Alterations in intratumorous thymopoiesis were reflected by corresponding alterations of naive T-cell subset composition in the blood, in that only MG(-) patients had significantly decreased levels (P =.02) of naive CD4(+) T cells compared with age- and sex-matched control persons. We conclude that paraneoplastic MG is highly associated with the efficiency of thymomas to produce and export naive CD4(+) T cells. The acquisition of the CD45RA(+) phenotype on CD4(+) T cells during terminal intratumorous thymopoiesis is associated with the presence of MG in most thymoma patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12070022     DOI: 10.1182/blood.v100.1.159

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  27 in total

1.  [Myasthenia gravis and thymolipoma: a rare variation of a well-known theme].

Authors:  M Schneider; U Eichfeld; A Beller; P Baum; J Claßen; F Then Bergh
Journal:  Nervenarzt       Date:  2012-08       Impact factor: 1.214

2.  Diffuse high intensity PD-L1 staining in thymic epithelial tumors.

Authors:  Sukhmani K Padda; Jonathan W Riess; Erich J Schwartz; Lu Tian; Holbrook E Kohrt; Joel W Neal; Robert B West; Heather A Wakelee
Journal:  J Thorac Oncol       Date:  2015-03       Impact factor: 15.609

3.  Multiple paraneoplastic diseases occurring in the same patient after thymomectomy.

Authors:  C Briani; A Cagnin; S Blandamura; G Altavilla
Journal:  J Neurooncol       Date:  2010-02-10       Impact factor: 4.130

Review 4.  Expression of cell cycle and apoptosis regulators in thymus and thymic epithelial tumors.

Authors:  Alexandra Papoudou-Bai; Alexandra Barbouti; Vassiliki Galani; Kalliopi Stefanaki; Dimitra Rontogianni; Panagiotis Kanavaros
Journal:  Clin Exp Med       Date:  2015-03-21       Impact factor: 3.984

5.  Paraneoplastic diseases associated with thymoma.

Authors:  Amelia Evoli; Giacomo Maria Minicuci; Roberta Vitaliani; Alessandra Battaglia; Giacomo Della Marca; Libero Lauriola; Andrea Fattorossi
Journal:  J Neurol       Date:  2007-02-26       Impact factor: 4.849

6.  Immune-mediated diseases and immunodeficiencies associated with thymic epithelial neoplasms.

Authors:  Muhammad Rizwan Khawaja; Robert P Nelson; Nicholas Miller; Sunil S Badve; Elizabeth Loehrer; Magdalena Czader; Susan M Perkins; Kenneth Kesler; Patrick J Loehrer
Journal:  J Clin Immunol       Date:  2012-01-08       Impact factor: 8.317

7.  Thymopoiesis, regulatory T cells, and TCRVbeta expression in thymoma with and without myasthenia gravis, and modulatory effects of steroid therapy.

Authors:  Andrea Fattorossi; Alessandra Battaglia; Alexia Buzzonetti; Giacomo Minicuci; Raffaella Riso; Laura Peri; Giovanni Scambia; Amelia Evoli
Journal:  J Clin Immunol       Date:  2007-11-14       Impact factor: 8.317

Review 8.  Immunological function of thymoma and pathogenesis of paraneoplastic myasthenia gravis.

Authors:  Meinoshin Okumura; Yoshitaka Fujii; Hiroyuki Shiono; Masayoshi Inoue; Masato Minami; Tomoki Utsumi; Yoshihisa Kadota; Yoshiki Sawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2008-04-10

9.  Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis.

Authors:  Eva Tolosa; Weijie Li; Yoshiyuki Yasuda; Wolfgang Wienhold; Lisa K Denzin; Alfred Lautwein; Christoph Driessen; Petra Schnorrer; Ekkehard Weber; Stefan Stevanovic; Raffael Kurek; Arthur Melms; Dieter Bromme
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

10.  Paraneoplastic Syndromes and Thymic Malignancies: An Examination of the International Thymic Malignancy Interest Group Retrospective Database.

Authors:  Sukhmani K Padda; Xiaopan Yao; Alberto Antonicelli; Jonathan W Riess; Yue Shang; Joseph B Shrager; Robert Korst; Frank Detterbeck; James Huang; Bryan M Burt; Heather A Wakelee; Sunil S Badve
Journal:  J Thorac Oncol       Date:  2017-11-27       Impact factor: 15.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.